So I made a post yesterday about creating a new series of posts around general information. Many of my newsletters, especially the Anthology Series, partially had the assumption that my readers would be able to understand most of the information that I presented. Of course, that’s a bad assumption to make so I’ve decided to start making a so-called “Mini Lesson” set of posts that people can refer to for more information about a topic that can be used to supplement gaps in knowledge. With these posts will also come a section called Applied Knowledge that will ask some basic questions and try to have you apply the knowledge you have just learned. Answers to these questions will be posted at a later time in a paid-members post but feel free to ask any questions about the topic or about clarification on content/Applied Knowledge questions. And please provide feedback in regards to my approach to these topics!
All this to say that, apparently, my post yesterday was too long and didn’t send through the email. The first Mini Lesson is on Pharmacology, so please take a look and let me know what you think:
I can see you how you want to be a teacher. I expected the introduction to pharmacology to be boring, but actually you made it quite engaging and easy to understand. Well done! 👏
I appreciate the sentiments, I guess not many people share the same interests in drug design as I do! I was actually considering becoming a medicinal chemist since I found this stuff so fascinating but considering what's happening within the pharmaceutical community I became a bit disenfranchised.
But more on that later. I do hope that these posts will be accessible to laymen.
I can see you how you want to be a teacher. I expected the introduction to pharmacology to be boring, but actually you made it quite engaging and easy to understand. Well done! 👏
I appreciate the sentiments, I guess not many people share the same interests in drug design as I do! I was actually considering becoming a medicinal chemist since I found this stuff so fascinating but considering what's happening within the pharmaceutical community I became a bit disenfranchised.
But more on that later. I do hope that these posts will be accessible to laymen.